Anticoagulants Update: What Geriatrics Providers Need to Know

Moderator: Michael W. Rich, MD

This symposium will provide geriatrics providers with an evidence-based update on anticoagulation management in older adults, addressing atrial fibrillation, venous thromboembolism, emerging therapies, deprescribing, and individualized decision-making across care settings. Learning Objectives: (1) evaluate the risks and benefits of anticoagulation strategies in older adults with atrial fibrillation, venous thromboembolism, and complex comorbidities; (2) apply current evidence and guideline recommendations to anticoagulation decision-making in geriatric and long-term care settings; (3) individualize anticoagulation therapy by incorporating patient-specific factors such as frailty, cognitive impairment, fall risk, renal function, and goals of care; (4) integrate emerging anticoagulation therapies into clinical practice while considering safety, efficacy, and applicability in older adults; and (5) identify clinical scenarios in which deprescribing anticoagulants is appropriate and implement safe deprescribing strategies.

Introduction
Michael W. Rich, MD

Atrial Fibrillation: Anticoagulation or Left Atrial Appendage Occlusion? 
Darae Ko, MD

Anticoagulation for Atrial Fibrillation in Long-Term Care: What is the Evidence? 
Michael W. Rich, MD

Emerging Anticoagulation Therapies in Older Adults: Factor XIa Inhibitors and Beyond 
Brian F. Gage, MD

Deprescribing Anticoagulants in Older Adults: When to Say When 
Sunny Linnebur, PharmD

Anticoagulation for DVT: What Is the Best Option for my Patient? 
Andrew Zullo, PharmD